The effects of time-restricted feeding on lipid metabolism and adiposity

Adipocyte

Volumn 4, Issue 4, 2015, Pages 319-324

  Chaix, Amandine ^a   Zarrinpar, Amir ^a,b  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Circadian rhythm; Diabesity; Diabetes; Dyslipidemia; Dysmetabolism; Fasting; Metabolism; Steatohepatitis; Steatosis

Indexed keywords

ADIPOCYTOKINE; BILE ACID;

ADIPOCYTE; ARTICLE; DIET INDUCED OBESITY; DIET RESTRICTION; DIETARY INTAKE; DYSLIPIDEMIA; FATTY LIVER; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; LIPID METABOLISM; METABOLOME; MICROBIOME; OBESITY;

EID: 85027550921     PISSN: 21623945     EISSN: 2162397X     Source Type: Journal    
DOI: 10.1080/21623945.2015.1025184     Document Type: Article

References (36)

1. Huang W, Ramsey KM, Marcheva B, Bass J. Circadian rhythms, sleep, and metabolism. J Clin Invest 2011; 121:2133-41. PMID:21633182. http://dx.doi.org/10.1172/JCI46043
2. Bass J, Takahashi JS. Circadian integration of metabolism and energetics. Science 2010; 330:1349-54. PMID:21127246. http://dx.doi.org/10.1126/science.1195027
3. Chaix A, Zarrinpar A, Miu P, Panda S. Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges. Cell Metab 2014; 20:991-1005. PMID:25470547. http://dx.doi.org/10.1016/j.cmet.2014.11.001
4. Hatori M, Vollmers C, Zarrinpar A, DiTacchio L, Bushong EA, Gill S, Leblanc M, Chaix A, Joens M, Fitzpatrick JA, et al. Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab 2012; 15:848-60. PMID:22608008. http://dx.doi.org/10.1016/j.cmet.2012.04.019
5. Zarrinpar A, Chaix A, Yooseph S, Panda S. Diet and feeding pattern affect the diurnal dynamics of the gut microbiome. Cell Metab 2014; 20:1006-17. PMID:25470548. http://dx.doi.org/10.1016/j.cmet.2014.11.008
6. Sherman H, Genzer Y, Cohen R, Chapnik N, Madar Z, Froy O. Timed high-fat diet resets circadian metabolism and prevents obesity. FASEB J 2012; 26:3493-502. PMID:22593546. http://dx.doi.org/10.1096/fj.12-208868
7. Vollmers C, Gill S, DiTacchio L, Pulivarthy SR, Le HD, Panda S. Time of feeding and the intrinsic circadian clock drive rhythms in hepatic gene expression. Proc Natl Acad Sci U S A 2009; 106:21453-8. PMID:19940241. http://dx.doi.org/10.1073/pnas.0909591106
8. Kohsaka A, Laposky AD, Ramsey KM, Estrada C, Joshu C, Kobayashi Y, Turek FW, Bass J. High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab 2007; 6:414-21. PMID:17983587. http://dx.doi.org/10.1016/j.cmet.2007.09.006
9. West DB, York B. Dietary fat, genetic predisposition, and obesity: lessons from animal models. Am J Clin Nutr 1998; 67:505S-12S. PMID:9497161
10. Cho H, Zhao X, Hatori M, Yu RT, Barish GD, Lam MT, Chong LW, DiTacchio L, Atkins AR, Glass CK, et al. Regulation of circadian behaviour and metabolism by REV-ERB-alpha and REV-ERB-beta. Nature 2012; 485:123-7. PMID:22460952. http://dx.doi.org/10.1038/nature11048
11. Greiner T, Backhed F. Effects of the gut microbiota on obesity and glucose homeostasis. Trends Endocrinol Metab 2011; 22:117-23. PMID:21353592. http://dx.doi.org/10.1016/j.tem.2011.01.002
12. Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest 2011; 121:2126-32. PMID:21633181. http://dx.doi.org/10.1172/JCI58109
13. Tremaroli V, Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012; 489:242-9. PMID:22972297. http://dx.doi.org/10.1038/nature11552
14. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012; 482:179-85. PMID:22297845
15. Li F, Jiang C, Krausz KW, Li Y, Albert I, Hao H, Fabre KM, Mitchell JB, Patterson AD, Gonzalez FJ. Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat Commun 2013; 4:2384. PMID:24064762
16. Mukherji A, Kobiita A, Ye T, Chambon P. Homeostasis in intestinal epithelium is orchestrated by the circadian clock and microbiota cues transduced by TLRs. Cell 2013; 153:812-27. PMID:23663780. http://dx.doi.org/10.1016/j.cell.2013.04.020
17. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444:1027-31. PMID:17183312. http://dx.doi.org/10.1038/nature05414
18. Joyce SA, MacSharry J, Casey PG, Kinsella M, Murphy EF, Shanahan F, Hill C, Gahan CG. Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut. Proc Natl Acad Sci U S A 2014; 111:7421-6. PMID:24799697. http://dx.doi.org/10.1073/pnas.1323599111
19. Million M, Angelakis E, Maraninchi M, Henry M, Giorgi R, Valero R, Vialettes B, Raoult D. Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli. Int J Obesity 2013; 37:1460-6. PMID:23459324. http://dx.doi.org/10.1038/ijo.2013.20
20. Million M, Maraninchi M, Henry M, Armougom F, Richet H, Carrieri P, Valero R, Raccah D, Vialettes B, Raoult D. Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int J Obesity 2012; 36:817-25. PMID:21829158. http://dx.doi.org/10.1038/ijo.2011.153
21. Raman M, Ahmed I, Gillevet PM, Probert CS, Ratcliffe NM, Smith S, Greenwood R, Sikaroodi M, Lam V, Crotty P, et al. Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2013; 11:868-75 e1-3. PMID:23454028. http://dx.doi.org/10.1016/j.cgh.2013.02.015
22. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, et al. Diet rapidly alters the human gut microbiome. Nature 2014; 505:559-63. PMID: 24336217. http://dx.doi.org/10.1038/nature12820
23. Duncan SH, Lobley GE, Holtrop G, Ince J, Johnstone AM, Louis P, Flint HJ. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obesity 2008; 32:1720-4. PMID:18779823. http://dx.doi.org/10.1038/ijo.2008.155
24. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, Keilbaugh SA, Hamady M, Chen YY, Knight R, Ahima RS, Bushman F, Wu GD. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 2009; 137:1716-24. PMID:19706296. http://dx.doi.org/10.1053/j.gastro.2009.08.042
25. Hagey LR, Krasowski MD. Microbial biotransformations of bile acids as detected by electrospray mass spectrometry. Adv Nutr 2013; 4:29-35. PMID:23319120. http://dx.doi.org/10.3945/an.112.003061
26. Calkin AC, Tontonoz P. Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat Rev Mol Cell Biol 2012; 13:213-24. PMID:22414897
27. Cariou B, van Harmelen K, Duran-Sandoval D, van Dijk TH, Grefhorst A, Abdelkarim M, Caron S, Torpier G, Fruchart JC, Gonzalez FJ, et al. The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. J Biol Chem 2006; 281:11039-49. PMID:16446356. http://dx.doi.org/10.1074/jbc.M510258200
28. Duran-Sandoval D, Cariou B, Percevault F, Hennuyer N, Grefhorst A, van Dijk TH, Gonzalez FJ, Fruchart JC, Kuipers F, Staels B, et al. The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition. J Biol Chem 2005; 280:29971-9. PMID:15899888. http://dx.doi.org/10.1074/jbc.M501931200
29. Kuipers F, Bloks VW, Groen AK. Beyond intestinal soap–bile acids in metabolic control. Nat Rev Endocrinol 2014; 10:488-98. PMID:24821328. http://dx.doi.org/10.1038/nrendo.2014.60
30. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014; 311:806-14. http://dx.doi.org/10.1001/jama.2014.732
31. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payerand service-specific estimates. Health Aff 2009; 28: w822-31. PMID:19635784. http://dx.doi.org/10.1377/hlthaff.28.5.w822
32. Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess 2009; 13:1-190, 215-357, iii-iv. PMID:19726018. http://dx.doi.org/10.3310/hta13410
33. Karlsson B, Knutsson A, Lindahl B. Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27,485 people. Occup Environ Med 2001; 58:747-52. PMID:11600731. http://dx.doi.org/10.1136/oem.58.11.747
34. Reutrakul S, Hood MM, Crowley SJ, Morgan MK, Teodori M, Knutson KL, Van Cauter E. Chronotype is independently associated with glycemic control in type 2 diabetes. Diabetes Care 2013; 36:2523-9. PMID:23637357. http://dx.doi.org/10.2337/dc12-2697
35. Cahill LE, Chiuve SE, Mekary RA, Jensen MK, Flint AJ, Hu FB, Rimm EB. Prospective study of breakfast eating and incident coronary heart disease in a cohort of male US health professionals. Circulation 2013; 128:337-43. PMID:23877060. http://dx.doi.org/10.1161/CIRCULATIONAHA.113.001474
36. Fang S, Suh JM, Reilly SM, Yu E, Osborn O, Lackey D, Yoshihara E, Perino A, Jacinto S, Lukasheva Y, et al. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance. Nature Med 2015; 21(2):159-65. PMID:25559344. http://dx.doi.org/10.1038/nm.3760